Variable | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95%CI | P value | HR | 95% CI | P value | |
Age (60 y vs. > 60 y) | 0.949 | 0.604–1.492 | 0.820 | |||
Gender | 1.739 | 1.032–2.931 | 0.038 | 1.884 | 1.039–3.133 | 0.036 |
T stage (T1 vs. T2–4) | 5.526 | 1.353–22.574 | 0.017 | 1.137 | 0.149–8.949 | 0.903 |
N stage (N0 vs. N1–3) | 1.850 | 1.192–2.870 | 0.006 | 1.374 | 0.868–2.176 | 0.176 |
AJCC clinical staging (I vs. II–III) | 9.119 | 1.265–65.707 | 0.028 | 7.383 | 0.417–134.348 | 0.172 |
Pathological grading (I vs. II–III) | 1.234 | 0.752–2.024 | 0.405 | |||
Ki67 (< 14% vs. ≥ 14%) | 1.539 | 0.893–2.653 | 0.120 | |||
BRAF (weakly vs. strongly) | 2.087 | 1.131–3.853 | 0.019 | 2.782 | 1.444–5.361 | 0.002 |